EUVIMEDEUVIMED entdecken
Crossref

Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities

Tatsuro Nakamura iD, Shunsuke Nakagawa, Shogo Horikawa, Jun Nagahama, Yuki Yasudome iD, Takanari Abematsu, Yuichi Kodama iD, Takuro Nishikawa iD, Yasuhiro Okamoto iD

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 02.07.2025. Verfasst von Tatsuro Nakamura und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Midazolam, Neoplasms, Hypnotics and Sedatives, Ketamine. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Children with developmental disabilities (DDs) tend to have more fear of loud noises and needles than those without. However, how DDs affect sedation during painful procedures in pediatric patients with cancer is unclear. This study aimed to evaluate the sedative doses and adverse events (AEs) associated with sedation using a combination of midazolam and ketamine for bone marrow aspiration and intrathecal therapy.

Methods

The AEs evaluated included hypoxia, vomiting, tremors, excitement, disturbances, apnea, and bradycardia. The study included seven participants with autism spectrum disorder, attention deficit hyperactivity disorder, and specific learning disorders, alongside 30 control participants without DD. The types of cancers included acute lymphoblastic leukemia, acute myeloid leukemia, and diffuse large B‐cell lymphoma. A total of 107 procedures were performed in the DD group and 378 in the control group.

Results

There were no significant differences in the sedative doses and AEs between patients with DD and controls, except for increased tremors after sedation in the DD group.

Conclusions

Sedation using a combination of midazolam and ketamine can be safely performed for painful procedures in pediatric patients with cancer and DD without excessive concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidazolamNeoplasmsHypnotics and SedativesKetamineDevelopmental DisabilitiesProcedural SedationHumansFemaleMaleChildChild, PreschoolAdolescentCase-Control StudiesInjections, Spinal

Stichwörter der Autor:innen

adverse eventscancerdevelopmental disabilitiespediatricssedation

Substanzen

MidazolamHypnotics and SedativesKetamine

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.

ORCID-Profile: Tatsuro Nakamura, Yuki Yasudome, Yuichi Kodama, Takuro Nishikawa, Yasuhiro Okamoto

Zitieren

APA

Nakamura, T., Nakagawa, S., Horikawa, S., Nagahama, J., Yasudome, Y., Abematsu, T., Kodama, Y., Nishikawa, T., & Okamoto, Y. (2025). Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70142

Vancouver

Nakamura T, Nakagawa S, Horikawa S, Nagahama J, Yasudome Y, Abematsu T, et al. Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities. Pediatrics International. 2025;67(1). doi:10.1111/ped.70142

BibTeX
@article{Nakamura2025,
  author = {Nakamura, Tatsuro and Nakagawa, Shunsuke and Horikawa, Shogo and Nagahama, Jun and Yasudome, Yuki and Abematsu, Takanari and Kodama, Yuichi and Nishikawa, Takuro and Okamoto, Yasuhiro},
  title = {Safety and efficacy of sedation for pediatric patients with cancer and developmental disabilities},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.70142}
}
Kostenlos starten →